JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.95% |
| 2 | Financials | 11.95% |
| 3 | Healthcare | 9.46% |
| 4 | Consumer Discretionary | 8.62% |
| 5 | Industrials | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4151
INNOVATE Corp
VATE
$105M
| $415K | ﹤0.01% |
19,117
+3,378
| +21% | +$74.3K |
|
4152
USA Compression Partners
USAC
$3.84B
| $414K | ﹤0.01% |
22,828
+22,732
| +23,679% | +$388K |
|
|
MAXR
4153
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $414K | ﹤0.01% |
26,428
+6,834
| +35% | +$71K |
|
|
CMO
4154
DELISTED
Capstead Mortgage Corp.
CMO
| $414K | ﹤0.01% |
52,259
-766,205
| -94% | -$5.92M |
|
4155
Valhi
VHI
$463M
| $413K | ﹤0.01% |
18,397
-16,155
| -47% | -$371K |
|
|
PDLI
4156
DELISTED
PDL BioPharma, Inc.
PDLI
| $413K | ﹤0.01% |
127,270
-637,799
| -83% | -$1.85M |
|
4157
WisdomTree US MidCap Fund
EZM
$957M
| $412K | ﹤0.01% |
9,797
+711
| +8% | +$28.9K |
|
4158
Syndax Pharmaceuticals
SNDX
$1.77B
| $412K | ﹤0.01% |
46,935
+10,580
| +29% | +$77.7K |
|
|
MCBC
4159
DELISTED
Macatawa Bank Corp
MCBC
| $412K | ﹤0.01% |
36,996
+28,469
| +334% | +$303K |
|
|
IEC
4160
DELISTED
IEC Electronics Corp.
IEC
| $409K | ﹤0.01% |
44,944
+1,406
| +3% | +$10.7K |
|
4161
iShares MSCI Qatar ETF
QAT
$63.6M
| $408K | ﹤0.01% |
22,956
-3
| -0% | -$53 |
|
|
TEF
4162
DELISTED
Telefonica
TEF
| $408K | ﹤0.01% |
72,601
+2,592
| +4% | +$15.7K |
|
4163
Travelzoo
TZOO
$75.5M
| $408K | ﹤0.01% |
38,157
-7,589
| -17% | -$78.7K |
|
|
SILK
4164
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $408K | ﹤0.01% |
10,114
+3,879
| +62% | +$136K |
|
4165
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.77B
| $406K | ﹤0.01% |
4,065
+3,679
| +953% | +$365K |
|
4166
UNIFI
UFI
$127M
| $406K | ﹤0.01% |
16,074
+11,346
| +240% | +$274K |
|
|
ATAXZ
4167
DELISTED
AMERICA FIRST TAX EXEMT INV LP
ATAXZ
| $406K | ﹤0.01% |
52,710
+27,834
| +112% | +$214K |
|
|
OMN
4168
DELISTED
OMNOVA Solutions Inc.
OMN
| $404K | ﹤0.01% |
39,944
+25,579
| +178% | +$258K |
|
4169
Clearfield
CLFD
$395M
| $403K | ﹤0.01% |
28,929
+10,029
| +53% | +$130K |
|
4170
Domo
DOMO
$184M
| $403K | ﹤0.01% |
18,542
+11,818
| +176% | +$218K |
|
|
BRT
4171
BRT Apartments
BRT
$268M
| $402K | ﹤0.01% |
23,686
+18,221
| +333% | +$307K |
|
4172
iShares 0-5 Year TIPS Bond ETF
STIP
$15.9B
| $402K | ﹤0.01% |
3,991
+131
| +3% | +$13.1K |
|
4173
CALL
Viatris
VTRS
$18.5B
| $402K | ﹤0.01% |
+20,000
| New | +$372K |
|
4174
CALL
Beyond Meat
BYND
$214M
| $401K | ﹤0.01% |
5,300
| – | – |
|
4175
Radiant Logistics
RLGT
$400M
| $401K | ﹤0.01% |
72,033
+58,559
| +435% | +$317K |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.